ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Short Term Outcomes in Previously Covid Positive Living Kidney Donors and Their Recipients

    R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Study short term outcomes of living kidney donors (LKD) who were previously infected with COVID 19, and in their recipients.*Methods: After a brief hiatus…
  • 2021 American Transplant Congress

    Nurse and Nurse Practitioner-lead Monoclonal Antibody Initiative for Solid Organ Transplant (sot) Recipients with Covid-19

    W. Cochran1, R. Avery2, D. Brennan2, N. Lawrence2, A. Brown2, S. Sullivan2, B. Adams2, M. McCarthy2, S. Ellis2, F. Naqvi2, E. Kraus2, N. Alachkar2, S. Alasfar2, F. Al Ammary2, J. Horn2, L. Hartman2, L. Fessler2, S. Purekal2, Z. Siddiqui2, D. Carter2, J. Ficke2, M. Kantsiper2, L. Boyer2, I. Gupta2, A. Gurakar2, D. Ostrander2, J. Langlee2, S. Shoham2, K. Marr2, P. Shah2

    1Johns Hopkins Comprehensive Transplant Center, Baltimore, MD, 2Johns Hopkins, Baltimore, MD

    *Purpose: Monoclonal antibody (mAB) infusion (bamlanivimab or casirivimab/imdevimab) for symptomatic, non-hypoxemic, high-risk outpatients with COVID-19 infection, is an available early intervention for COVID-19+ SOT recipients.…
  • 2021 American Transplant Congress

    Bamlanivimab for Covid-19 in Kidney Transplant Patients

    M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin

    Nephrology, Indiana University School of Medicine, Indianapolis, IN

    *Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…
  • 2021 American Transplant Congress

    Covid-19 Infections Post-liver and Kidney Transplantation in a Southern Ca Program

    M. E. de Vera1, J. Woloszyn2, S. Regmi2, R. Rattanavich2, M. Rakoski2, M. Lin2, P. Mehta2, A. Kore2, J. Weissman2, C. Martens2, T. Phan2, B. Jerez-Aguilar2, M. Robinson2, E. Wells2, R. Villicana2, M. Nguyen2

    1Loma Linda University Health, San Bernardino, CA, 2Transplant Institute, Loma Linda University Health, San Bernardino, CA

    *Purpose: Southern CA is at the epicenter of the Covid-19 pandemic. We reviewed outcomes of our center's liver, kidney, and pancreas transplant patients stricken with…
  • 2021 American Transplant Congress

    Sars-cov-2 Stat Testing for Organ Donation; One Laboratory’s Experience

    S. Dionne, B. O'Neale

    VRL-Eurofins, Centennial, CO

    *Purpose: The COVID-19 pandemic took the U.S. by storm. The Transplant Community had to navigate through unprecedented scenarios in order to continue the life-saving mission…
  • 2021 American Transplant Congress

    Impact of Covid-19 Infection on Tacrolimus Levels in Solid Organ Transplant Recipients

    K. Heagler, K. Tejani, S. Sanchez

    Loyola University Medical Center, Maywood, IL

    *Purpose: Immunocompromised patients are considered to be at high-risk for infection with SARS-CoV-2 (COVID-19). There have been observations within the transplant community that patients infected…
  • 2021 American Transplant Congress

    Combined CD11b/CD40 Blockade is Superior to CD40 Blockade Alone in Prolonging Survival in Pig-to-Nonhuman Primate Renal Xenotransplantation

    D. A. Faber1, B. Lovasik1, A. Matar1, C. Breeden1, S. Kim1, A. Adams2

    1Surgery, Emory University School of Medicine, Atlanta, GA, 2Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: Blockade of the CD40/CD154 pathway is highly effective in preventing rejection in pig-to-nonhuman primate (NHP) xenotransplantation models. Clinical translation of anti-CD154 mAbs, however, has…
  • 2021 American Transplant Congress

    Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

    L. Danziger-Isakov1, M. G. Michaels1, A. Agarwal1, S. Aslam1, K. Dunn1, J. Goldman1, D. Levine1, C. Marboe1, G. Marklin1, S. Pouch1, M. Rana1, R. Razonable1, H. L. Stevenson1, H. S. Te1, A. Woolley1, E. Ward2, C. Jett2, L. Cartwright2, R. La Hoz1

    1OPTN DTAC, Richmond, VA, 2UNOS, Richmond, VA

    *Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…
  • 2021 American Transplant Congress

    T-cell-Mediated Immunity to Sars-cov-2 Defines Covid-19 Risk and Severity in Transplanted and Non-Transplanted Individuals and Associates with Myeloid-Derived Suppressor Cells

    C. Ashokkumar1, V. Rohan2, A. H. Kroemer3, S. Rao4, G. Mazariegos5, B. W. Higgs5, S. Nadig2, M. Ningappa5, T. Fishbein3, S. Subramaniam6, R. Sindhi7

    1Plexision, Pittsburgh, PA, 2Medical University of South Carolina, Charleston, SC, 3MedStar Georgetown Transplant Institute, Georgetown, DC, 4DHR Health Institute for Research and Development, Texas, TX, 5University of Pittsburgh, Pittsburgh, PA, 6University of California, San Diego, CA, 7University of Pittsburgh, pittsburgh, PA

    *Purpose: We assessed whether COVID-19-risk is enhanced by chronic immunosuppression, and is associated with suppressor cells.*Methods: We tested 66 COVID-19 patients, including 26 with solid…
  • 2021 American Transplant Congress

    A Noninvasive Diagnostic Approach for Molecular Monitoring of Face Transplant Recipients

    C. Snopkowski1, P. Rabbani2, H. Yang1, Z. Berman2, G. Diep2, C. Li1, T. Muthukumar1, R. Ding1, D. Ceradini2, M. Suthanthiran1

    1Weill Cornell Medical Institute, Department of Medicine, Division of Nephrology, NY, NY, 2NYU Langone Health, Hansjörg Wyss Department of Plastic Surgery, NY, NY

    *Purpose: Skin biopsies are currently the gold standard for evaluating the inflammatory status of face allografts. However, “tape stripping” is emerging as a noninvasive technique…
  • « Previous Page
  • 1
  • …
  • 229
  • 230
  • 231
  • 232
  • 233
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences